Skip to main content
Top
Published in: Infection 5/2015

01-10-2015 | Case Report

Recipient-born bloodstream infection due to extensively drug-resistant Acinetobacter baumannii after emergency heart transplant: report of a case and review of the literature

Authors: Roberto Andini, Federica Agrusta, Irene Mattucci, Umberto Malgeri, Giusi Cavezza, Riccardo Utili, Emanuele Durante-Mangoni

Published in: Infection | Issue 5/2015

Login to get access

Abstract

Infections due to drug-resistant Gram-negative rods are an emerging risk factor for increased mortality after solid organ transplant. Extensively drug-resistant (XDR) Acinetobacter baumannii (Acb) is a major threat in several critical care settings. The limited available data on the outcome of XDR Acb infections in organ transplant recipients mostly comes from cases of donor-derived infections. However, recipients of life-saving organs are often critically ill patients, staying long term in intensive care units, and therefore at high risk for nosocomial infections. In this report, we describe our experience with the exceedingly complex management of a recipient-born XDR Acb bloodstream infection clinically ensued shortly after heart transplant. We also review the current literature on this mounting issue relevant for intensive care, transplant medicine and infectious diseases.
Literature
1.
go back to reference Husain S, Mooney ML, Danziger-Isakov L, Mattner F, Singh N, Avery R. A 2010 working formulation for the standardization of definitions of infections in cardiothoracic transplant recipients. J Heart Lung Transplant. 2011;30:361–74.CrossRefPubMed Husain S, Mooney ML, Danziger-Isakov L, Mattner F, Singh N, Avery R. A 2010 working formulation for the standardization of definitions of infections in cardiothoracic transplant recipients. J Heart Lung Transplant. 2011;30:361–74.CrossRefPubMed
2.
go back to reference Ison MG, Grossi P. Donor-derived infections in solid organ transplantation. Am J Transplant. 2013;13:22–30.CrossRefPubMed Ison MG, Grossi P. Donor-derived infections in solid organ transplantation. Am J Transplant. 2013;13:22–30.CrossRefPubMed
3.
go back to reference Bull DA, Stahll RD, McMahan DL, Jones KW, et al. The high risk heart donor: potential pitfalls. J Heart Lung Transplant. 1995;14:424–8.PubMed Bull DA, Stahll RD, McMahan DL, Jones KW, et al. The high risk heart donor: potential pitfalls. J Heart Lung Transplant. 1995;14:424–8.PubMed
4.
go back to reference Freeman RB, Giatras I, Falagas ME, et al. Outcome of transplantation of organs procured from bacteremic donors. Transplantation. 1999;68:1107–11.CrossRefPubMed Freeman RB, Giatras I, Falagas ME, et al. Outcome of transplantation of organs procured from bacteremic donors. Transplantation. 1999;68:1107–11.CrossRefPubMed
5.
go back to reference Nguyen M, Eschenauer GA, Bryan M, et al. Carbapenem-resistant Klebsiella pneumoniae bacteremia: factors correlated with clinical and microbiologic outcomes. Diagn Microbiol Infect Dis. 2010;67:180–4.CrossRefPubMed Nguyen M, Eschenauer GA, Bryan M, et al. Carbapenem-resistant Klebsiella pneumoniae bacteremia: factors correlated with clinical and microbiologic outcomes. Diagn Microbiol Infect Dis. 2010;67:180–4.CrossRefPubMed
6.
go back to reference Orlando G, Di Cocco P, Gravante G, D’Angelo M, Famulari A, Pisani F. Fatal hemorrhage in two renal graft recipients with multi-drug resistant Pseudomonas aeruginosa infection. Transplant Infect Dis. 2009;11:442–7.CrossRef Orlando G, Di Cocco P, Gravante G, D’Angelo M, Famulari A, Pisani F. Fatal hemorrhage in two renal graft recipients with multi-drug resistant Pseudomonas aeruginosa infection. Transplant Infect Dis. 2009;11:442–7.CrossRef
7.
go back to reference Pauly RP, Rayner D, Murray AG, Gilmour SM, Kunimoto DY. Transplantation in the face of severe donor sepsis: pushing the boundaries? Am J Kidney Dis. 2004;44:e64–7.CrossRefPubMed Pauly RP, Rayner D, Murray AG, Gilmour SM, Kunimoto DY. Transplantation in the face of severe donor sepsis: pushing the boundaries? Am J Kidney Dis. 2004;44:e64–7.CrossRefPubMed
8.
go back to reference Sifri CD, Ison MG. Highly resistant bacteria and donor-derived infections: treading in uncharted territory. Transplant Infect Dis. 2012;14:223–8.CrossRef Sifri CD, Ison MG. Highly resistant bacteria and donor-derived infections: treading in uncharted territory. Transplant Infect Dis. 2012;14:223–8.CrossRef
9.
go back to reference Veroux M, Corona D, Scriffignano V, et al. Contamination of preservation fluid in kidney transplantation: single-center analysis. Transplant Proc. 2010;42:1043–5.CrossRefPubMed Veroux M, Corona D, Scriffignano V, et al. Contamination of preservation fluid in kidney transplantation: single-center analysis. Transplant Proc. 2010;42:1043–5.CrossRefPubMed
10.
go back to reference Wakelin SJ, Casey J, Robertson A, et al. The incidence and importance of bacterial contaminants of cadaveric renal perfusion fluid. Transpl Int. 2005;17:680–6.CrossRefPubMed Wakelin SJ, Casey J, Robertson A, et al. The incidence and importance of bacterial contaminants of cadaveric renal perfusion fluid. Transpl Int. 2005;17:680–6.CrossRefPubMed
11.
go back to reference Watkins AC, Vedula GV, Horan J, et al. The deceased organ donor with an “open abdomen”: proceed with caution. Transplant Infect Dis. 2012;14:311–5.CrossRef Watkins AC, Vedula GV, Horan J, et al. The deceased organ donor with an “open abdomen”: proceed with caution. Transplant Infect Dis. 2012;14:311–5.CrossRef
12.
go back to reference Lumbreras C, Sanz F, González A, et al. Clinical significance of donor-unrecognized bacteremia in the outcome of solid-organ transplant recipients. Clin Infect Dis. 2001;33:722–6.CrossRefPubMed Lumbreras C, Sanz F, González A, et al. Clinical significance of donor-unrecognized bacteremia in the outcome of solid-organ transplant recipients. Clin Infect Dis. 2001;33:722–6.CrossRefPubMed
13.
go back to reference Magiorakos AP, Srinivasan A, Carey RB, et al. Multidrug-resistant, extensively drug-resistant and pandrug-resistant bacteria: an international expert proposal for interim standard definitions for acquired resistance. Clin Microbiol Infect. 2012;18:268–81.CrossRefPubMed Magiorakos AP, Srinivasan A, Carey RB, et al. Multidrug-resistant, extensively drug-resistant and pandrug-resistant bacteria: an international expert proposal for interim standard definitions for acquired resistance. Clin Microbiol Infect. 2012;18:268–81.CrossRefPubMed
14.
go back to reference Nunley DR, Bauldoff GS, Mangino JE, Pope-Harman AL. Mortality associated with Acinetobacter baumannii infections experienced by lung transplant recipients. Lung. 2010;188:381–5.CrossRefPubMed Nunley DR, Bauldoff GS, Mangino JE, Pope-Harman AL. Mortality associated with Acinetobacter baumannii infections experienced by lung transplant recipients. Lung. 2010;188:381–5.CrossRefPubMed
15.
go back to reference Durante-Mangoni E, Zarrilli R. Global spread of drug-resistant Acinetobacter baumannii: molecular epidemiology and management of antimicrobial resistance. Future Microbiol. 2011;6:407–22.CrossRefPubMed Durante-Mangoni E, Zarrilli R. Global spread of drug-resistant Acinetobacter baumannii: molecular epidemiology and management of antimicrobial resistance. Future Microbiol. 2011;6:407–22.CrossRefPubMed
16.
go back to reference Wareham DW, Gordon NC, Hornsey M. In vitro activity of teicoplanin combined with colistin versus multidrug-resistant strains of Acinetobacter baumannii. J Antimicrob Chemother. 2011;66:1047–51.CrossRefPubMed Wareham DW, Gordon NC, Hornsey M. In vitro activity of teicoplanin combined with colistin versus multidrug-resistant strains of Acinetobacter baumannii. J Antimicrob Chemother. 2011;66:1047–51.CrossRefPubMed
17.
go back to reference Hornsey M, Wareham DW. In vivo efficacy of glycopeptide-colistin combination therapies in a Galleria mellonella model of Acinetobacter baumannii infection. Antimicrob Agents Chemother. 2011;55:3534–7.PubMedCentralCrossRefPubMed Hornsey M, Wareham DW. In vivo efficacy of glycopeptide-colistin combination therapies in a Galleria mellonella model of Acinetobacter baumannii infection. Antimicrob Agents Chemother. 2011;55:3534–7.PubMedCentralCrossRefPubMed
18.
go back to reference O’Hara JA, Ambe LA, Casella LG, Townsend BM, et al. Activities of vancomycin-containing regimens against colistin-resistant Acinetobacter baumannii clinical strains. Antimicrob Agents Chemother. 2013;57:2103–8.PubMedCentralCrossRefPubMed O’Hara JA, Ambe LA, Casella LG, Townsend BM, et al. Activities of vancomycin-containing regimens against colistin-resistant Acinetobacter baumannii clinical strains. Antimicrob Agents Chemother. 2013;57:2103–8.PubMedCentralCrossRefPubMed
19.
go back to reference Durante-Mangoni E, Signoriello G, Andini R, et al. Colistin and rifampicin compared with colistin alone for the treatment of serious infections due to extensively drug-resistant Acinetobacter baumannii: a multicenter, randomized clinical trial. Clin Infect Dis. 2013;57:349–58.CrossRefPubMed Durante-Mangoni E, Signoriello G, Andini R, et al. Colistin and rifampicin compared with colistin alone for the treatment of serious infections due to extensively drug-resistant Acinetobacter baumannii: a multicenter, randomized clinical trial. Clin Infect Dis. 2013;57:349–58.CrossRefPubMed
20.
go back to reference Martins N, Martins IS, de Freitas WV, et al. Severe infection in a lung transplant recipient caused by donor-transmitted carbapenem-resistant Acinetobacter baumannii. Transpl Infect Dis. 2012;14:316–20.PubMedCentralCrossRefPubMed Martins N, Martins IS, de Freitas WV, et al. Severe infection in a lung transplant recipient caused by donor-transmitted carbapenem-resistant Acinetobacter baumannii. Transpl Infect Dis. 2012;14:316–20.PubMedCentralCrossRefPubMed
21.
go back to reference Simkins J, Muggia V. Favorable outcome in a renal transplant recipient with donor-derived infection due to multidrug-resistant Pseudomonas aeruginosa. Transpl Infect Dis. 2012;14:292–5.CrossRefPubMed Simkins J, Muggia V. Favorable outcome in a renal transplant recipient with donor-derived infection due to multidrug-resistant Pseudomonas aeruginosa. Transpl Infect Dis. 2012;14:292–5.CrossRefPubMed
22.
go back to reference Ariza-Heredia EJ, Patel R, Blumberg EA, et al. Outcomes of transplantation using organs from a donor infected with Klebsiella pneumoniae carbapenemase (KPC)-producing K. pneumoniae. Transpl Infect Dis. 2012;14:229–36.CrossRefPubMed Ariza-Heredia EJ, Patel R, Blumberg EA, et al. Outcomes of transplantation using organs from a donor infected with Klebsiella pneumoniae carbapenemase (KPC)-producing K. pneumoniae. Transpl Infect Dis. 2012;14:229–36.CrossRefPubMed
23.
go back to reference Kumar D, Cattral MS, Robicsek A, Gaudreau C, Humar A. Outbreak of pseudomonas aeruginosa by multiple organ transplantation from a common donor. Transplantation. 2003;15:1053–5.CrossRef Kumar D, Cattral MS, Robicsek A, Gaudreau C, Humar A. Outbreak of pseudomonas aeruginosa by multiple organ transplantation from a common donor. Transplantation. 2003;15:1053–5.CrossRef
24.
go back to reference Goldberg E, Bishara J, Lev S, Singer P, Cohen J. Organ transplantation from a donor colonized with a multidrug-resistant organism: a case report. Transpl Infect Dis. 2012;14:296–9.CrossRefPubMed Goldberg E, Bishara J, Lev S, Singer P, Cohen J. Organ transplantation from a donor colonized with a multidrug-resistant organism: a case report. Transpl Infect Dis. 2012;14:296–9.CrossRefPubMed
25.
go back to reference Reddy P, Zembower TR, Ison MG, Baker TA, Stosor V. Carbapenem-resistant Acinetobacter baumannii infections after organ transplantation. Transpl Infect Dis. 2010;12:87–93.CrossRefPubMed Reddy P, Zembower TR, Ison MG, Baker TA, Stosor V. Carbapenem-resistant Acinetobacter baumannii infections after organ transplantation. Transpl Infect Dis. 2010;12:87–93.CrossRefPubMed
Metadata
Title
Recipient-born bloodstream infection due to extensively drug-resistant Acinetobacter baumannii after emergency heart transplant: report of a case and review of the literature
Authors
Roberto Andini
Federica Agrusta
Irene Mattucci
Umberto Malgeri
Giusi Cavezza
Riccardo Utili
Emanuele Durante-Mangoni
Publication date
01-10-2015
Publisher
Springer Berlin Heidelberg
Published in
Infection / Issue 5/2015
Print ISSN: 0300-8126
Electronic ISSN: 1439-0973
DOI
https://doi.org/10.1007/s15010-015-0772-z

Other articles of this Issue 5/2015

Infection 5/2015 Go to the issue
Obesity Clinical Trial Summary

At a glance: The STEP trials

A round-up of the STEP phase 3 clinical trials evaluating semaglutide for weight loss in people with overweight or obesity.

Developed by: Springer Medicine

Highlights from the ACC 2024 Congress

Year in Review: Pediatric cardiology

Watch Dr. Anne Marie Valente present the last year's highlights in pediatric and congenital heart disease in the official ACC.24 Year in Review session.

Year in Review: Pulmonary vascular disease

The last year's highlights in pulmonary vascular disease are presented by Dr. Jane Leopold in this official video from ACC.24.

Year in Review: Valvular heart disease

Watch Prof. William Zoghbi present the last year's highlights in valvular heart disease from the official ACC.24 Year in Review session.

Year in Review: Heart failure and cardiomyopathies

Watch this official video from ACC.24. Dr. Biykem Bozkurt discusses last year's major advances in heart failure and cardiomyopathies.